Stock Events

Stock Events

KalVista Pharmaceuticals (4XC1.MU) Q2 2026 Earnings

14MayConfirmed

Q4 2025

Q2 2026

-0.8

-0.65

-0.5

-0.35

Details

Expected EPS

-0.35006388089999996

Actual EPS

N/A

Surprise EPS

0.35

Surprise Percent

+100%

Description

KalVista Pharmaceuticals (4XC1.MU) will report earnings of for Q2 2026 on May 14, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.